These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9160342)

  • 1. Positron emission tomography, magnetic resonance imaging and proton NMR spectroscopy of white matter in multiple sclerosis.
    Schiepers C; Van Hecke P; Vandenberghe R; Van Oostende S; Dupont P; Demaerel P; Bormans G; Carton H
    Mult Scler; 1997 Feb; 3(1):8-17. PubMed ID: 9160342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical alterations in multiple sclerosis lesions and normal-appearing white matter detected by in vivo 31P and 1H spectroscopic imaging.
    Husted CA; Goodin DS; Hugg JW; Maudsley AA; Tsuruda JS; de Bie SH; Fein G; Matson GB; Weiner MW
    Ann Neurol; 1994 Aug; 36(2):157-65. PubMed ID: 8053651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR-based correction of brain PET measurements for heterogeneous gray matter radioactivity distribution.
    Meltzer CC; Zubieta JK; Links JM; Brakeman P; Stumpf MJ; Frost JJ
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):650-8. PubMed ID: 8964805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balo's concentric sclerosis followed by MRI and positron emission tomography.
    Hanemann CO; Kleinschmidt A; Reifenberger G; Freund HJ; Seitz RJ
    Neuroradiology; 1993; 35(8):578-80. PubMed ID: 8278034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapsing-remitting multiple sclerosis: metabolic abnormality in nonenhancing lesions and normal-appearing white matter at MR imaging: initial experience.
    He J; Inglese M; Li BS; Babb JS; Grossman RI; Gonen O
    Radiology; 2005 Jan; 234(1):211-7. PubMed ID: 15528260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis: hyperintense lesions in the brain on T1-weighted MR images assessed by diffusion tensor imaging.
    Zhou F; Shiroishi M; Gong H; Zee CS
    J Magn Reson Imaging; 2010 Apr; 31(4):789-95. PubMed ID: 20373421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
    Steen C; D'haeseleer M; Hoogduin JM; Fierens Y; Cambron M; Mostert JP; Heersema DJ; Koch MW; De Keyser J
    Mult Scler; 2013 Sep; 19(10):1282-9. PubMed ID: 23428956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1H MRSI of normal appearing white matter in multiple sclerosis.
    Rooney WD; Goodkin DE; Schuff N; Meyerhoff DJ; Norman D; Weiner MW
    Mult Scler; 1997 Aug; 3(4):231-7. PubMed ID: 9372505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of multiple sclerosis patients with magnetic resonance spectroscopic imaging.
    Peters AR; Geelen JA; den Boer JA; Prevo RL; Minderhoud JM; 's Gravenmade EJ
    Mult Scler; 1995 Apr; 1(1):25-31. PubMed ID: 9345466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance spectroscopy of memory and frontal brain region in early multiple sclerosis.
    Staffen W; Zauner H; Mair A; Kutzelnigg A; Kapeller P; Stangl H; Raffer E; Niederhofer H; Ladurner G
    J Neuropsychiatry Clin Neurosci; 2005; 17(3):357-63. PubMed ID: 16179658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
    Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
    Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study.
    Pulizzi A; Rovaris M; Judica E; Sormani MP; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2007 Aug; 64(8):1163-8. PubMed ID: 17698707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis.
    Tartaglia MC; Narayanan S; De Stefano N; Arnaoutelis R; Antel SB; Francis SJ; Santos AC; Lapierre Y; Arnold DL
    J Neurol; 2002 Oct; 249(10):1382-90. PubMed ID: 12382153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
    Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
    J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative glucose metabolic rate higher in white matter in patients with schizophrenia.
    Buchsbaum MS; Buchsbaum BR; Hazlett EA; Haznedar MM; Newmark R; Tang CY; Hof PR
    Am J Psychiatry; 2007 Jul; 164(7):1072-81. PubMed ID: 17606659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
    Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
    J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between MRI and PET changes and cognitive disturbances in MS.
    Sørensen PS; Jønsson A; Mathiesen HK; Blinkenberg M; Andresen J; Hanson LG; Ravnborg M
    J Neurol Sci; 2006 Jun; 245(1-2):99-102. PubMed ID: 16650436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.